{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05452005",
            "orgStudyIdInfo": {
                "id": "1718953"
            },
            "organization": {
                "fullName": "University of California, Davis",
                "class": "OTHER"
            },
            "briefTitle": "Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer",
            "officialTitle": "Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography for Staging, Response Assessment, and Patient Selection in Metastatic Non-Small Cell Lung Cancer",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "fluorine-binding-peptide-positron-emission-tomography-in-metastatic-non-small-cell-lung-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-28",
            "studyFirstSubmitQcDate": "2022-07-06",
            "studyFirstPostDateStruct": {
                "date": "2022-07-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-16",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Julie L. Sutcliffe, Ph.D",
                "investigatorTitle": "Professor of Internal Medicine and Biomedical Engineering",
                "investigatorAffiliation": "University of California, Davis"
            },
            "leadSponsor": {
                "name": "University of California, Davis",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "United States Department of Defense",
                    "class": "FED"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study investigates fluorine-18-AlphaVBeta6-BP (\\[18F\\]-\u03b1v\u03b26-BP) as a Positron Emission (PET) imaging agent in Non-Small Cell Lung Cancer (NSCLC) patients with brain metastases. Investigators hypothesize that \\[18F\\]-\u03b1v\u03b26-BP PET/Computed Tomography (CT) is a sensitive tool for disease assessment in patients with metastatic NSCLC, including those with brain metastases.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nThe primary objective of this study is to evaluate the sensitivity and specificity of \\[18F\\]-\u03b1v\u03b26-BP PET/CT for detecting metastases in patients with NSCLC.\n\nOUTLINE:\n\nPatients will undergo \\[18F\\]-\u03b1v\u03b26-BP PET/CT at baseline in addition to standard-of-care \\[18F\\]-2-fluoro-2-deoxy-D-glucose (FDG) PET/CT body and magnetic resonance imaging (MRI) of the brain. Patients will then undergo standard-of-care cancer directed therapy. Patients will be re-staged 8-12 weeks later at the next standard-of-care imaging time point with \\[18F\\]-\u03b1v\u03b26-BP PET/CT, \\[18F\\]-FDG PET/CT, and MRI."
        },
        "conditionsModule": {
            "conditions": [
                "Lung Cancer",
                "Lung Cancer Metastatic",
                "Brain Metastases",
                "Non Small Cell Lung Cancer"
            ],
            "keywords": [
                "Positron Emission Tomography"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Experimental [18F]-\u03b1v\u03b26-BP",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive \\[18F\\]-\u03b1v\u03b26-BP BP IV and then undergo a PET/CT scan over 30 minutes 60 minutes post-injection.",
                    "interventionNames": [
                        "Drug: [18F]-\u03b1v\u03b26-BP"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "[18F]-\u03b1v\u03b26-BP",
                    "description": "Subjects will be injected twice with up to 10 millicurie (mCi) of 18F-\u03b1v\u03b26-BP as a rapid intravenous (i.v) bolus.",
                    "armGroupLabels": [
                        "Experimental [18F]-\u03b1v\u03b26-BP"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "[18F]-\u03b1v\u03b26-BP PET/CT imaging compared to immunohistochemistry",
                    "description": "Standard uptake value (SUV) values from \\[18F\\]-\u03b1v\u03b26-BP PET/CT will be compared to immunohistochemistry (IHC) \u03b1v\u03b26 staining of archival tissue to assess the sensitivity of \\[18F\\]-\u03b1v\u03b26-BP PET/CT to detect \u03b1v\u03b26 positive metastasis in NSCLC",
                    "timeFrame": "Up to six months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Comparison of standard-of-care MRI and [18F]-\u03b1v\u03b26-BP PET/CT imaging",
                    "description": "Detection of lesions with \\[18F\\]-\u03b1v\u03b26-BP will be compared to the number of lesions identified during standard-of-care MRI imaging",
                    "timeFrame": "Up to six months"
                },
                {
                    "measure": "Comparison of standard-of-care [18F]-FDG PET/CT and [18F]-\u03b1v\u03b26-BP PET/CT imaging",
                    "description": "SUVmax values obtained during standard-of-care FDG/PET will be compared to SUVmax values obtained from \\[18F\\]-\u03b1v\u03b26-BP PET/CT imaging",
                    "timeFrame": "Up to six months"
                },
                {
                    "measure": "Comparison of standard-of-care MRI brain and [18F]-FDG PET/CT and [18F]-\u03b1v\u03b26-BP PET/CT imaging post treatment",
                    "description": "Lesion response will be assessed based on standard-of-care MRI images, \\[18F\\]-FDG PET/CT and \\[18F\\]-\u03b1v\u03b26-BP PET/CT post treatment.",
                    "timeFrame": "Up to six months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Men and women age \\>18 yrs\n2. Biopsy proven NSCLC with brain metastases (treated or untreated)\n3. Life-expectancy of \u22653 months in the opinion of the treating physician\n4. Available archival tumor tissue (excisional, core, or fine needle aspiration (FNA) is acceptable). Tissue from a metastatic site is preferred when available.\n5. Able to tolerate all study procedures, including remain motionless for up to 30-60 minutes per scan\n6. Ability to understand and willingness to sign a written informed consent document.\n7. Planned to undergo additional cancer-directed therapy followed by standard-of-care re-staging imaging\n8. \\[18F\\]-FDG PET/CT within 21 days of enrollment\n9. MRI brain within 21 days of enrollment\n10. Eastern Cooperative Oncology Group Performance Status \u2264 2\n11. Glomerular filtration rate (GFR) \u2265 60\n\nExclusion Criteria:\n\n1. Pregnant or lactating women\n2. Prisoners\n3. Concurrent malignancy of a different histology that could confound imaging interpretation\n4. Patients who cannot undergo PET/CT scanning because of weight limits(\\>350lbs)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Principal Investigator",
                    "role": "CONTACT",
                    "phone": "916-734-5536",
                    "email": "jlsutcliffe@ucdavis.edu"
                },
                {
                    "name": "Julie L Sutcliffe",
                    "role": "CONTACT",
                    "phone": "9167345536",
                    "email": "jlsutcliffe@ucdavis.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Julie L. Sutcliffe, PhD",
                    "affiliation": "The Regents of the University of California (Davis)",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The University of California Davis Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julie L Sutcliffe",
                            "role": "CONTACT",
                            "phone": "916-734-5536",
                            "email": "jlsutcliffe@ucdavis.edu"
                        },
                        {
                            "name": "Megan Daly, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                },
                {
                    "id": "D000001932",
                    "term": "Brain Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                },
                {
                    "id": "D000016543",
                    "term": "Central Nervous System Neoplasms"
                },
                {
                    "id": "D000009423",
                    "term": "Nervous System Neoplasms"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5209",
                    "name": "Brain Neoplasms",
                    "asFound": "Brain Metastases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M18937",
                    "name": "Central Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12367",
                    "name": "Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M8587",
                    "name": "Fluorides",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}